News and insights

Zuzana Tothova has a weakness for uncharted territory. It has inspired her to pursue an ambitious project at the Ó³»­´«Ã½ of MIT and Harvard where she’s using a slew of novel technologies to better understand a blood disorders called myelodysplastic syndrome (MDS). But this weakness for the unknown runs deep and can even be blamed for how she found herself in the United States in the first place.